Guillain‐Barré syndrome and COVID‐19: A 1‐year observational multicenter study

Many single cases and small series of Guillain–Barré syndrome (GBS) associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection were reported during the coronavirus disease 19 (COVID‐19) outbreak worldwide. However, the debate regarding the possible role of infection in causing GBS is still ongoing. This multicenter study aimed to evaluate epidemiological and clinical findings of GBS diagnosed during the COVID‐19 pandemic in northeastern Italy in order to further investigate the possible association between GBS and COVID‐19.

[1]  K. Khunti,et al.  Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection , 2021, Nature Medicine.

[2]  R. Garg,et al.  COVID‐19‐associated Guillain‐Barre syndrome: Postinfectious alone or neuroinvasive too? , 2021, Journal of medical virology.

[3]  A. Padovani,et al.  Electrophysiological features of acute inflammatory demyelinating polyneuropathy associated with SARS-CoV-2 infection , 2021, Neurophysiologie Clinique.

[4]  Biyan Nathanael Harapan,et al.  Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) , 2021, Journal of Neurology.

[5]  S. Farhadian,et al.  Neuroinvasion of SARS-CoV-2 in human and mouse brain , 2021, The Journal of experimental medicine.

[6]  M. Sojka,et al.  SARS-CoV-2 RNA in the Cerebrospinal Fluid of a Patient with Long COVID , 2021, Therapeutic advances in infectious disease.

[7]  Ò. Miró,et al.  Incidence, clinical, risk factors and outcomes of Guillain‐Barré in Covid‐19 , 2020, Annals of Neurology.

[8]  M. Filippi,et al.  Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[9]  Z. Siddiqi,et al.  Guillain Barré syndrome and COVID-19: Possible role of the cytokine storm , 2020, Autoimmunity Reviews.

[10]  M. Aarabi,et al.  Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms , 2020, Molecular Neurobiology.

[11]  J. Vallat,et al.  Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[12]  H. Tumani,et al.  Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases , 2020, Journal of Neurology.

[13]  S. Farmer,et al.  Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome , 2020, medRxiv.

[14]  R. Lewis,et al.  COVID‐19–associated Guillain‐Barré syndrome: The early pandemic experience , 2020, Muscle & nerve.

[15]  P. Manganotti,et al.  Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain‐Barré syndrome and polyneuritis cranialis in COVID‐19 patients: A case series , 2020, Journal of medical virology.

[16]  M. Leonardi,et al.  Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy , 2020, Neurology.

[17]  G. Gigli,et al.  Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster? , 2020, Journal of Neurology.

[18]  F. J. Carod-Artal.  Neurological complications of coronavirus and COVID-19. , 2020, Revista de neurologia.

[19]  A. Amato,et al.  COVID-19 and neuromuscular disorders , 2020, Neurology.

[20]  Hannah R. Meredith,et al.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.

[21]  Amjad D. Al-Nasser,et al.  SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far , 2020, Pathogens.

[22]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[23]  S. Kuwabara,et al.  The electrodiagnosis of Guillain-Barré syndrome subtypes: Where do we stand? , 2018, Clinical Neurophysiology.

[24]  J. Anaya,et al.  Clinical and nerve conduction features in Guillain−Barré syndrome associated with Zika virus infection in Cúcuta, Colombia , 2018, European journal of neurology.

[25]  Luigi Ippoliti,et al.  Optimizing the electrodiagnostic accuracy in Guillain-Barré syndrome subtypes: Criteria sets and sparse linear discriminant analysis , 2017, Clinical Neurophysiology.

[26]  B. Jacobs,et al.  Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis , 2014, Nature Reviews Neurology.

[27]  R. Porcher,et al.  Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  J. Sejvar,et al.  Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. , 2011, Vaccine.

[29]  H. Hartung,et al.  Guillain-Barré syndrome after exposure to influenza virus. , 2010, The Lancet. Infectious diseases.

[30]  A. McGrogan,et al.  The Epidemiology of Guillain-Barré Syndrome Worldwide , 2008, Neuroepidemiology.

[31]  N. Cleveland.  Guillan-Barré Syndrome: Incidence and Mortality Rates in US Hospitals , 2008 .

[32]  E. Steyerberg,et al.  A clinical prognostic scoring system for Guillain-Barré syndrome , 2007, The Lancet Neurology.

[33]  Ettore Beghi,et al.  Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996 , 2004, Acta neurologica Scandinavica.

[34]  L. Wilkins.  A Prospective Study on the Incidence and Prognosis of Guillain-Barre Syndrome in Emilia-Romagna Region, Italy (1992-1993) , 1997, Neurology.

[35]  J. Cherry,et al.  Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence. , 1994, The Journal of pediatrics.

[36]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[37]  O. Junttila,et al.  Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré Syndrome. , 1998, American journal of epidemiology.